Son, Julie Y <br/><br/>
Oral pretreatment with recombinant human lactoferrin limits trauma-hemorrhagic shock-induced gut injury and the biological activity of mesenteric lymph.  [electronic resource] 

 -  The Journal of surgical research  Mar 2014 
 - 270-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-8673 
<br/><br/><label>Standard No.: </label>10.1016/j.jss.2013.10.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Ileum--drug effects<br/>Lactoferrin--pharmacology<br/>Laparotomy--adverse effects<br/>Lymph--drug effects<br/>Lymphatic System--drug effects<br/>Male<br/>Neutrophils--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recombinant Proteins--pharmacology<br/>Reperfusion Injury--etiology<br/>Respiratory Burst--drug effects<br/>Shock, Hemorrhagic--drug therapy<br/>Wounds and Injuries--complications